Zomedica Corp. Deferred Federal Income Tax Expense (Benefit)
Zomedica Corp. (ZOMDF) reported Deferred Federal Income Tax Expense (Benefit) of -$192.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-16
- Zomedica Corp. deferred federal income tax expense (benefit) for fiscal 2025 was -$192.00K.
- Zomedica Corp. deferred federal income tax expense (benefit) for fiscal 2024 was -$638.00K.
- Zomedica Corp. deferred federal income tax expense (benefit) for fiscal 2023 was -$1.55M.
- Zomedica Corp. deferred federal income tax expense (benefit) for fiscal 2022 was -$2.31M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$192.00K 10-K · filed 2026-03-16 |
| 2024-12-31 | -$638.00K 10-K · filed 2026-03-16 |
| 2023-12-31 | -$1.55M 10-K · filed 2025-03-13 |
| 2022-12-31 | -$2.31M 10-K · filed 2024-04-01 |